Denali Capital Acquisition Corp. Extends Business Combination Deadline to March 11, 2025

Semnur Pharmaceuticals, Inc.

Deposited $15,036.74 into trust account to extend deadline for completing a business combination by one month.
Extension moves deadline from February 11, 2025 to March 11, 2025.
Funding from a convertible promissory note issued to Scilex Holding Company (SCLX) with a principal amount of up to $180,000.
Note is non-interest bearing, repayable upon business combination or liquidation, and convertible into Class A ordinary shares at $10.00 per share at Scilex's option.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.